KDM6B and benign prostatic hyperplasia: A previous study searched the Oncomine database and one set of data showed that the KDM6B mRNA expression rates in benign prostate hyperplasia, PCa, and metastatic PCa were 4.8%, 16%, and 55%, respectively25.